NICOLAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicolar, and when can generic versions of Nicolar launch?
Nicolar is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in NICOLAR is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicolar
A generic version of NICOLAR was approved as niacin by BARR on April 14th, 2005.
Summary for NICOLAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Patent Applications: | 4,052 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NICOLAR at DailyMed |
US Patents and Regulatory Information for NICOLAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | NICOLAR | niacin | TABLET;ORAL | 083823-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |